Market revenue in 2023 | USD 60.5 million |
Market revenue in 2030 | USD 128.2 million |
Growth rate | 11.3% (CAGR from 2023 to 2030) |
Largest segment | Sequencing by synthesis |
Fastest growing segment | Sequencing by synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequencing by synthesis, Sequencing by ligation, Sanger sequencing |
Key market players worldwide | Microbiome Insights Inc., BaseClear, Clinical Microbiomics, Mérieux NutriSciences Corporation, Mr Dna, Metabiomics, Rancho BioSciences, Second Genome, Zymo Research, uBiome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbiome sequencing services market will help companies and investors design strategic landscapes.
Sequencing by synthesis was the largest segment with a revenue share of 58.84% in 2023. Horizon Databook has segmented the Germany microbiome sequencing services market based on sequencing by synthesis, sequencing by ligation, sanger sequencing covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is considered a potential market owing to strategic initiatives undertaken by key players operating in microbiome sequencing services market. They offer services ranging from library preparation to final bioinformatics data interpretation along with post-delivery support related to sequencing services at moderate cost for both local and international customers.
For instance, QIAGEN is engaged in offering a wide range of sequencing services such as single-read services, verification services, de novo sequencing, genome services, and special services including microbiome sequencing.
Moreover, in July 2018, the company partnered with Freenome, a San Francisco-based artificial intelligence genomics company, for development & commercialization of NGS tests for cancer management. This collaboration was aimed at expanding the company’s presence in sequencing services space.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany microbiome sequencing services market , including forecasts for subscribers. This country databook contains high-level insights into Germany microbiome sequencing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account